CD4 T CELL DEPENDENT B CELL ACTIVATION IN AIDS LYMPHOMAS

艾滋病淋巴瘤中 CD4 T 细胞依赖性 B 细胞激活

基本信息

  • 批准号:
    2108355
  • 负责人:
  • 金额:
    $ 24.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-09-01 至 1998-08-31
  • 项目状态:
    已结题

项目摘要

One of the frequent consequences of chronic HIV infection is the development of AIDS associated lymphomas. These are uniformly high grade malignancies of B lymphocytes, and they fall into three histological categories: (i) small, noncleaved cell; (ii) large immunoblastic/plasmacytoid cell; and (3), large cell lymphoma. Involvement of Epstein-Barr virus (EBV) is frequently seen in the immunoblastic tumors, while the other tumor categories show frequent c- myc rearrangements and mutations of the p53 tumor suppressor gene. While EBV+ immunoblastic lymphomas have been observed in HIV infection of hu- PBL-SCID mice, the other AIDS-associated lymphomas have not been seen. We propose to study the link between HIV infection and chronic B cell activation, using PBL derived from HIV-infected individuals as well as normal PBL infected in the context of the hu-PBL-SCID model. The specific aims of the project are to determine the response of resting, peripheral blood B cells or tonsillar, germinal center B cells to T cells or T cell clones infected with HIV or expressing HIV gp120 or gp41. CD4 T cell clones will be chosen on the basis of cytokine production to represent either the Th0, Th1, or Th2 subset. Selected combinations of T cell clones and B cells will be introduced into SCID mice to assess the extent of in vivo B cell proliferation, differentiation, and incidence of tumor formation. Peripheral blood B cells, tonsilar B cells, and follicular dendritic cells will be derived from normal donors and PBL from normal and HIV-seropositive donors. EBV seropositive donors who do not give rise to spontaneous tumors will be used. We will also examine expression of B cell genes that might block apoptosis and represent the first step towards malignant transformation under the differing conditions of T cell stimulation outlined in Aim 1. Expression of bcl-2 and the Epstein-Barr virus genes LMP (which transactivates bcl-2 expression), EBNA-2, and ZEBRA will be analyzed by a sensitive RNase protection assay. PBL and germinal center B cells from EBV-positive and EBV-negative donors will be compared. Finally, we will determine the relationship between different HIV-1 strains and specific activation of B cells expressing the VH3 immunoglobulin variable region. Preliminary evidence shows a correlation between the HIV strain used to infect hu- PBL-SCID mice, the rate of CD4 T cell depletion, and the extent of VH3 B cell stimulation. These data suggest that different gp120 molecules may interact differently with the Ig receptor on VH3-expressing B cells, and/or that the extent of CD4 T cell activation following HIV infection differs markedly among different virus strains.
慢性艾滋病毒感染的常见后果之一是

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epstein-Barr virus and lymphoproliferative disease.
Epstein-Barr 病毒和淋巴组织增生性疾病。
  • DOI:
    10.1097/00062752-199901000-00005
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mosier,DE
  • 通讯作者:
    Mosier,DE
Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co‐infection
存在或不存在人类免疫缺陷病毒(HIV)合并感染的阿根廷血友病患者中丙型肝炎(HCV)基因型和病毒滴度分布
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    G. Picchio;M. Nakatsuno;C. Boggiano;Rebecca Sabbe;M. Corti;J. Daruich;R. PÉREZ‐BIANCO;M. Tezanos;Robert Kokka;J. Wilber;D. Mosier
  • 通讯作者:
    D. Mosier
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONALD E MOSIER其他文献

DONALD E MOSIER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONALD E MOSIER', 18)}}的其他基金

Novel Mechanisms for Coreceptor Switching
共受体切换的新机制
  • 批准号:
    8602642
  • 财政年份:
    2013
  • 资助金额:
    $ 24.92万
  • 项目类别:
Novel Mechanisms for Coreceptor Switching
共受体切换的新机制
  • 批准号:
    8707961
  • 财政年份:
    2013
  • 资助金额:
    $ 24.92万
  • 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
  • 批准号:
    8434156
  • 财政年份:
    2011
  • 资助金额:
    $ 24.92万
  • 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
  • 批准号:
    8238279
  • 财政年份:
    2011
  • 资助金额:
    $ 24.92万
  • 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
  • 批准号:
    8627538
  • 财政年份:
    2011
  • 资助金额:
    $ 24.92万
  • 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
  • 批准号:
    8113111
  • 财政年份:
    2011
  • 资助金额:
    $ 24.92万
  • 项目类别:
Cross-reactive HERV immunity to combat HIV-1 infection
交叉反应性 HERV 免疫对抗 HIV-1 感染
  • 批准号:
    7914339
  • 财政年份:
    2009
  • 资助金额:
    $ 24.92万
  • 项目类别:
HIV Coreceptor Switching
HIV辅助受体转换
  • 批准号:
    7902978
  • 财政年份:
    2009
  • 资助金额:
    $ 24.92万
  • 项目类别:
Cross-reactive HERV immunity to combat HIV-1 infection
交叉反应性 HERV 免疫对抗 HIV-1 感染
  • 批准号:
    7737332
  • 财政年份:
    2009
  • 资助金额:
    $ 24.92万
  • 项目类别:
Improved Humanized Mouse Models for Vaccine Development
用于疫苗开发的改进人源化小鼠模型
  • 批准号:
    7689165
  • 财政年份:
    2008
  • 资助金额:
    $ 24.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了